Quarterly Results Trend: A Clear Upward Trajectory

The latest quarter saw a notable rise in the proportion of companies posting positive results, climbing to 56.0% from 46.0% in December 2025, 44.0% in September 2025, and 41.0% in June 2025. This steady improvement over the past year highlights a strengthening earnings environment amid evolving macroeconomic conditions.

Such a trend suggests that businesses are increasingly adapting to cost pressures and demand fluctuations, with many sectors benefiting from easing input costs and stabilising consumer sentiment. The upward momentum in earnings is a positive signal for investors seeking quality growth opportunities.

Market Capitalisation Breakdown: Mid Caps Lead the Charge

Analysing results by market capitalisation reveals that mid-cap companies outperformed their large- and small-cap peers in terms of positive earnings outcomes. Specifically, 66.0% of mid-cap stocks reported positive results, compared to 55.0% of small caps and 51.0% of large caps.

This outperformance by mid caps may reflect their greater agility and exposure to growth segments, as well as the benefits of operating in niche markets less impacted by global headwinds. Large caps, while more stable, continue to face challenges from global supply chain disruptions and inflationary pressures, which may have tempered their earnings growth.

Sectoral Highlights: Standout Performers and Emerging Themes

Among the top performers, the Non-Banking Financial Company (NBFC) sector was led by Muthoot Finance, which delivered robust results, reinforcing its position as a sector leader. The capital markets segment saw Multi Commodity Exchange (Multi Comm. Exc.) emerge as a top mid-cap performer, benefiting from increased trading volumes and market volatility.

In the small-cap space, the realty sector was prominently represented by Puravankara, which posted strong earnings growth driven by improved sales and project execution. Specialty chemicals and transport services also featured among the top small-cap performers, with Navin Fluorine International and Navkar Corporation respectively delivering impressive results.

Exceptional Quarterly Performance: Viyash Scientific Ltd. Shines

Among the 161 companies that declared results in the last 24 hours, Viyash Scientific Ltd., a pharmaceuticals and biotechnology firm, stood out with an outstanding financial performance for the March 2026 quarter. The company’s net sales surged by 129.02% to ₹919.96 crores, marking its highest quarterly sales to date.

Operating profit to interest ratio reached a peak of 12.69 times, underscoring efficient cost management and strong operational leverage. Profit before tax (excluding other income) soared by 629.29% to ₹109.32 crores, while net profit after tax grew by an impressive 446.4% to ₹52.11 crores. The company also recorded its highest PBDIT at ₹184.25 crores.

Despite a slight dip in its mojo score from 35 to 33 over the past three months, Viyash Scientific’s bullish stance since 13 May 2026 at ₹224.55 reflects investor confidence in its growth trajectory and robust fundamentals.

Upcoming Earnings to Watch

Market participants will closely monitor the earnings announcements of several heavyweight companies scheduled for 21 May 2026, including Max Healthcare Institute Ltd, GAIL (India) Ltd, and ITC Ltd. These results are expected to provide further clarity on sectoral trends and broader economic recovery prospects.

Aggregate Profit Growth and Market Implications

The aggregate earnings growth reflected in this quarter’s results is a testament to improving corporate health across sectors. The rise in positive results from 41.0% in June 2025 to 56.0% in March 2026 indicates a broad-based recovery that could underpin sustained market gains.

Investors should note the relative strength of mid-cap stocks, which have demonstrated resilience and growth potential. However, large caps remain critical for portfolio stability, especially given their global linkages and dividend yields.

Sectoral leaders in NBFCs, capital markets, realty, specialty chemicals, and transport services offer targeted opportunities for investors seeking thematic exposure aligned with earnings momentum.

Conclusion: Earnings Season Signals Renewed Optimism

The March 2026 quarterly results season has delivered encouraging signs of recovery and growth across market capitalisations and sectors. With 56.0% of companies reporting positive results, up from 41.0% just nine months ago, the earnings landscape is improving steadily.

Strong performances from mid-cap companies and select small caps highlight pockets of robust growth, while large caps continue to navigate global challenges with measured progress. Investors would do well to monitor upcoming results from key players and consider diversified exposure to capitalise on this earnings upswing.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →